黄斑浮腫・黄斑変性治療薬の世界市場予測および分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Macular Edema and Macular Degeneration - Global Drug Forecast and Market Analysis to 2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 27
2.1 Related Reports 28
3 Disease Overview 29
3.1 Macular Degeneration Overview 29
3.1.1 Etiology and Pathophysiology 31
3.1.2 Classification 35
3.1.3 Symptoms and Diagnosis 37
3.2 Macular Edema Overview 40
3.2.1 Etiology and Pathophysiology 41
3.2.2 Classification 44
3.2.3 Symptoms and Diagnosis 45
4 Epidemiology – Macular Edema 48
4.1 Disease Background 48
4.2 Risk Factors and Comorbidities 48
4.3 Global Trends 49
4.3.1 US 50
4.3.2 5EU 50
4.3.3 Japan 51
4.4 Forecast Methodology 51
4.4.1 Sources Used 52
4.4.2 Sources Not Used 54
4.4.3 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetes 55
4.4.4 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetic Retinopathy 59
4.4.5 Forecast Assumptions and Methods – Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 60
4.4.6 Forecast Assumptions and Methods – Total Prevalent Cases of ME following BRVO and CRVO 61
4.5 Epidemiological Forecast for Macular Edema (2013-2023) 62
4.5.1 Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 62
4.5.2 Age-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 64
4.5.3 Sex-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 66
4.5.4 Total Prevalent Cases of ME Following BRVO 68
4.5.5 Age-Specific Total Prevalent Cases of ME Following BRVO 70
4.5.6 Sex-Specific Total Prevalent Cases of ME following BRVO 72
4.5.7 Total Prevalent Cases of ME Following CRVO 74
4.5.8 Age-Specific Total Prevalent Cases of ME Following CRVO 76
4.5.9 Sex-Specific Total Prevalent Cases of ME Following CRVO 78
4.6 Discussion 80
4.6.1 Epidemiological Forecast Insight 80
4.6.2 Limitations of the Analysis 81
4.6.3 Strengths of the Analysis 82
5 Epidemiology – Age-Related Macular Degeneration 83
5.1 Disease Background 83
5.2 Risk Factors and Comorbidities 84
5.3 Global Trends 85
5.3.1 US 85
5.3.2 5EU 86
5.3.3 Japan 86
5.4 Forecast Methodology 87
5.4.1 Sources Used 88
5.4.2 Forecast Assumptions and Methods 90
5.5 Epidemiological Forecast for AMD (2013-2023) 94
5.5.1 Total Prevalent Cases of AMD 94
5.5.2 Age-Specific Total Prevalent Cases of AMD 95
5.5.3 Sex-Specific Total Prevalent Cases of AMD 97
5.5.4 Age-Standardized Total Prevalence of AMD 99
5.5.5 Total Prevalent Cases of AMD by Stage 101
5.5.6 Total Prevalent Cases of Late AMD by Subtype 102
5.6 Discussion 104
5.6.1 Epidemiological Forecast Insight 104
5.6.2 Limitations of the Analysis 105
5.6.3 Strengths of the Analysis 106
6 Disease Management 107
6.1 Diagnosis and Treatment Overview 107
6.1.1 Macular Edema Diagnosis 107
6.1.2 Macular Degeneration Diagnosis 107
6.1.3 Treatment Guidelines and Leading Prescribed Drugs 108
6.1.4 Clinical Practice 110
6.2 US 123
6.3 France 127
6.4 Germany 130
6.5 Italy 133
6.6 Spain 136
6.7 UK 139
6.8 Japan 142
7 Competitive Assessment 145
7.1 Overview 145
7.2 Product Profiles – Major Brands 146
7.2.1 Lucentis (ranibizumab) 146
7.2.2 Eylea (aflibercept) 157
7.2.3 Avastin (bevacizumab) 168
7.2.4 Macugen (pegaptanib sodium) 175
7.2.5 Visudyne (verteporfin) 178
7.2.6 Corticosteroid Implants 183
8 Unmet Need and Opportunity 195
8.1 Overview 195
8.2 Treatment for Dry AMD 196
8.2.1 Unmet Need 196
8.2.2 Gap Analysis 198
8.2.3 Opportunity 200
8.3 Longer-Acting Anti-VEGF Drug Therapy 202
8.3.1 Unmet Need 202
8.3.2 Gap Analysis 204
8.3.3 Opportunity 204
8.4 Increased Efficacy of Anti-VEGF Therapy for wAMD 205
8.4.1 Unmet Need 205
8.4.2 Gap Analysis 206
8.4.3 Opportunity 207
8.5 Less Invasive Drug Formulations 207
8.5.1 Unmet Need 207
8.5.2 Gap Analysis 208
8.5.3 Opportunity 209
8.6 Awareness and Earlier Patient Diagnosis 210
8.6.1 Unmet Need 210
8.6.2 Gap Analysis 211
8.6.3 Opportunity 211
8.7 Home Monitoring of AMD Progression 212
8.7.1 Unmet Need 212
8.7.2 Gap Analysis 213
8.7.3 Opportunity 214
9 Pipeline Assessment 216
9.1 Overview 216
9.2 Clinical Trial Mapping 217
9.3 Promising Drugs in Clinical Development 218
9.3.1 Abicipar pegol 220
9.3.2 Fovista 227
9.3.3 Squalamine 235
9.3.4 Lampalizumab 243
9.3.5 Emixustat 250
9.3.6 Optina 257
9.3.7 DE-102 265
9.4 Promising Drugs in Early-Stage Development 269
9.4.1 Complement Inhibitors 269
9.5 Other Drugs in Development 271
9.6 Biosimilars 273
10 Current and Future Players 275
10.1 Overview 275
10.2 Trends in Corporate Strategy 277
10.3 Company Profiles 278
10.3.1 Roche/Genentech 278
10.3.2 Novartis 282
10.3.3 Regeneron 285
10.3.4 Bayer 289
10.3.5 Valeant 293
10.3.6 Allergan 296
10.3.7 Alimera Sciences 299
10.3.8 Ampio Pharmaceuticals 303
10.3.9 Ophthotech 305
10.3.10 Acucela 309
10.3.11 Ohr Pharmaceuticals 313
11 Market Outlook 316
11.1 Global Markets 316
11.1.1 Forecast 316
11.1.2 Drivers and Barriers – Global Issues 324
11.2 US 327
11.2.1 Forecast 327
11.2.2 Key Events 333
11.2.3 Drivers and Barriers 333
11.3 France 335
11.3.1 Forecast 335
11.3.2 Key Events 341
11.3.3 Drivers and Barriers 341
11.4 Germany 345
11.4.1 Forecast 345
11.4.2 Key Events 350
11.4.3 Drivers and Barriers 350
11.5 Italy 353
11.5.1 Forecast 353
11.5.2 Key Events 360
11.5.3 Drivers and Barriers 360
11.6 Spain 364
11.6.1 Forecast 364
11.6.2 Key Events 369
11.6.3 Drivers and Barriers 369
11.7 UK 372
11.7.1 Forecast 372
11.7.2 Key Events 378
11.7.3 Drivers and Barriers 378
11.8 Japan 382
11.8.1 Forecast 382
11.8.2 Key Events 388
11.8.3 Drivers and Barriers 388
12 Appendix 392
12.1 Bibliography 392
12.2 Abbreviations 427
12.3 Methodology 434
12.4 Forecasting Methodology 434
12.4.1 Diagnosed ME and AMD Patients 434
12.4.2 Percentage of Drug-Treated Patients 435
12.4.3 Drugs Included in Each Therapeutic Class 435
12.4.4 Launch and Patent Expiry Dates 435
12.4.5 General Pricing Assumptions 436
12.4.6 Individual Drug Assumptions 437
12.4.7 Pricing of Pipeline Agents 442
12.5 Primary Research – KOLs Interviewed for this Report 443
12.6 Primary Research – High-Prescribers Survey 444
12.7 About the Authors 445
12.7.1 Analyst 445
12.7.2 Therapy Area Director 445
12.7.3 Epidemiologist 446
12.7.4 Global Head of Healthcare 446
12.8 About GlobalData 447
12.9 Disclaimer 447


【レポート販売概要】

■ タイトル:黄斑浮腫・黄斑変性治療薬の世界市場予測および分析
■ 英文:PharmaPoint: Macular Edema and Macular Degeneration - Global Drug Forecast and Market Analysis to 2023
■ 発行日:2014年10月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC111PIDR
■ 調査対象地域:グローバル
  • 世界のLTEメトロセル(Metrocell)市場動向(2014-2018)
    TechNavio's analysts forecast the Global LTE Metrocells market to grow at a CAGR of 93.68 percent over the period 2013-2018. One of the key factors contributing to this market growth is the Steady Rise of Data Applications. The Global LTE Metrocells Market has also been witnessing the emergence of Wi-Fi enabled small cells. However, the interference of metrocell networks with macrocell networks co …
  • スマート変圧器の世界市場:電力変圧器、配電変圧器、特殊変圧器、計器用変圧器
    The report offers detailed analysis of the global smart transformer market, which is growing in sync with rising power demand, expanding power distribution networks, and increasing investments to make power grids smart and efficient. The market has been geographically segmented into regions including Asia-Pacific, North America, Europe, Middle East, South America, and Africa. The market has been s …
  • 複合包装の世界市場2016-2020
    About Composite PackagingPaperboard composite cans are mainly used in the packaging of a wide range of food and beverages products, including snacks and instant beverages, soups and sauces. A paperboard composite can's end closures, one or both, are permanently affixed and have a convolute wound or spiral wound to form a rigid body. The can's body has several layers of paperboard materials, includ …
  • 世界の軍事シミュレーション及び仮想訓練市場:競争状況及び戦略的インサイト
    Summary This report shows the leading Military Simulation and Virtual Training market segments in various regions across the world. Details of top companies active across the global Military Simulation and Virtual Training market are provided, together with market size and forecast 2015-2025 for the main players across those areas. Key Findings The report provides a detailed analysis of the compet …
  • 医療産業向けモバイルソリューションの世界市場:モバイル端末、モバイルアプリ、エンタープライズ・プラットフォーム
    The global healthcare mobility solutions market is expected to grow at a lucrative CAGR of 25% to 30% during the forecast period (2015 to 2020). Factors such as rising adoption of mobile computers such as smartphones and tablets in healthcare systems, rising focus on patient-centric applications, better cost efficiency of mobility solutions resulting in streamlined workflow, shortage of nursing st …
  • 高速攻撃艇(FAC)の世界市場2017-202:ミサイル搭載FAC、ミサイル非搭載FAC
    About Fast Attack Craft FAC are small, fast, agile, and attack-capable warships, which are armed with anti-ship missiles, guns, or torpedoes. FAC are generally operated in the coastal regions as they lack the defensive capabilities to survive in the blue waters. The major benefit of such ships over other warships is their affordability and speed. These boats, when armed with guided missiles, are c …
  • Melrose Resources plc:石油・ガスバリューチェーン分析レポート2013
    Melrose Resources plc Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Melrose Resources plc" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Melrose Resources plc”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report e …
  • グローバルセイボリースナック 市場におけるM&A動向(2014年3月)
    Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global savory snacks market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global savory snacks market throughout the month. Additionally, the report provides an overview of all th …
  • BRIC(ブラジル/ロシア/インド/中国)の膀胱鏡(医療機器)市場
    BRIC Cystoscopes Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Cystoscopes Market Outlook to 2020", provides key market data on the BRIC Cystoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Cystoscopes and Non-Video Cystoscopes (Rigid Non-Video Cystoscopes and Flexible …
  • 世界の永久磁石市場(2014-2018)
    About Permanent Magnets Permanent magnets are materials which retain their magnetic properties permanently. In other words, they exhibit magnetic properties even if they are removed from a magnetic field. Permanent magnets can be broadly classified into rare earth, ferrite, aluminum-nickel-cobalt (Alnico), and other magnets. The rare earth magnets can be further subdivided into neodymium-iron-boro …
  • Tullow Oil plc:石油・ガスバリューチェーン分析レポート2013
    Tullow Oil plc Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Tullow Oil plc" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Tullow Oil plc”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s …
  • 世界のシリアル(穀物)食品材料市場動向と予測(~2019)
    Breakfast cereals are generally made of whole grains such as oats, wheat, rice, barley, rye, and other grains. Whole grains consist of the intact, ground, cracked, or flaked caryopsis, whose principal anatomical components such as the starchy endosperm, germ, and bran. These are present in the same relative proportions as they exist in the intact caryopsis. Thus, whole grains are good sources of f …
  • 電気トラックの世界市場:種類別(軽トラック、中型トラック、大型トラック)、用途別(農村部向け、都市部向け、長距離)、地域別予測
    Global Electric Truck Market to reach USD xxxx billion by 2025. Global Electric Truck Market valued approximately USD xxxx billion in 2016 is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2017-2025. Growing penetration of electric and hybrid power technologies in commercial vehicles, especially within city limits, will drive the demand for new types of dr …
  • ガーナの発電市場2016:市場動向、制度、競争状況
    Ghana Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations, and Competitive Landscape Summary This report elaborates Ghana's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Ghana power market’s regulatory structure, import and export trends, competitive landscape, and power projects …
  • 多発性硬化症:企業と競争環境
    PharmaPoint: Multiple Sclerosis - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Multiple Sclerosis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Multiple Sclerosis Market. The report identifies and analyses the key companies shaping and driving the gl …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。